LINGO-1 antibody ameliorates myelin impairment and spatial memory deficits in experimental autoimmune encephalomyelitis mice

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Sun, Jun Jun ^a   Ren, Qing Guo ^a   Xu, Lin ^b,c   Zhang, Zhi Jun ^a  

^a SOUTHEAST UNIVERSITY   (China)

^b KUNMING INSTITUTE OF ZOOLOGY   (China)

^c UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

[No Author keywords available]

Indexed keywords

LINGO1 PROTEIN, MOUSE; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; NERVE PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; TARGET OF RAPAMYCIN KINASE;

ANIMAL; ANTAGONISTS AND INHIBITORS; DISEASE MODEL; DRUG EFFECTS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; IMMUNOLOGY; MALE; MAZE TEST; METABOLISM; MOUSE; MULTIPLE SCLEROSIS; MYELIN SHEATH; PATHOLOGY; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION; SPATIAL MEMORY;

ANIMALS; ANTIBODIES, MONOCLONAL; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; MALE; MAZE LEARNING; MEMBRANE PROTEINS; MICE; MULTIPLE SCLEROSIS; MYELIN SHEATH; NERVE TISSUE PROTEINS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; SPATIAL MEMORY; TOR SERINE-THREONINE KINASES;

EID: 84941964240     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep14235     Document Type: Article

References (39)

1. Chiaravalloti, N. D. & DeLuca, J. Cognitive impairment in multiple sclerosis. Te Lancet. Neurology 7, 1139-1151 (2008).
2. Strober, L. B. et al. Unemployment in multiple sclerosis: the contribution of personality and disease. Multiple sclerosis (Houndmills, Basingstoke, England) 18, 647-653 (2012).
3. D'Intino, G. et al. Cognitive defcit associated with cholinergic and nerve growth factor down-regulation in experimental allergic encephalomyelitis in rats. Proceedings of the National Academy of Sciences of the United States of America 102, 3070-3075 (2005).
4. Rahn, K. A. et al. Inhibition of glutamate carboxypeptidase II (GCPII) activity as a treatment for cognitive impairment in multiple sclerosis. Proceedings of the National Academy of Sciences of the United States of America 109, 20101-20106 (2012).
5. Ziehn, M. O., Avedisian, A. A., Tiwari-Woodruf, S. & Voskuhl, R. R. Hippocampal CA1 atrophy and synaptic loss during experimental autoimmune encephalomyelitis, EAE. Laboratory investigation; a journal of technical methods and pathology 90, 774-786 (2010).
6. Funfschilling, U. et al. Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity. Nature 485, 517-521 (2012).
7. Lee, Y. et al. Oligodendroglia metabolically support axons and contribute to neurodegeneration. Nature 487, 443-448 (2012).
8. Nave, K. A. Myelination and support of axonal integrity by glia. Nature 468, 244-252 (2010).
9. McTigue, D. M. & Tripathi, R. B. Te life, death, and replacement of oligodendrocytes in the adult CNS. Journal of neurochemistry 107, 1-19 (2008).
10. Mifsud, G., Zammit, C., Muscat, R., Di Giovanni, G. & Valentino, M. Oligodendrocyte pathophysiology and treatment strategies in cerebral ischemia. CNS neuroscience & therapeutics 20, 603-612 (2014).
11. Bartzokis, G. Alzheimer's disease as homeostatic responses to age-related myelin breakdown. Neurobiology of aging 32, 1341-1371 (2011).
12. Butts, B. D., Houde, C. & Mehmet, H. Maturation-dependent sensitivity of oligodendrocyte lineage cells to apoptosis: implications for normal development and disease. Cell death and diferentiation 15, 1178-1186 (2008).
13. Fields, R. D. White matter in learning, cognition and psychiatric disorders. Trends in neurosciences 31, 361-370 (2008).
14. Akbar, N. et al. Difusion tensor imaging abnormalities in cognitively impaired multiple sclerosis patients. Te Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 37, 608-614 (2010).
15. Fink, F. et al. Te association between California Verbal Learning Test performance and fbre impairment in multiple sclerosis: evidence from difusion tensor imaging. Multiple sclerosis (Houndmills, Basingstoke, England) 16, 332-341 (2010).
16. Mesaros, S. et al. Difusion tensor MRI tractography and cognitive impairment in multiple sclerosis. Neurology 78, 969-975 (2012).
17. Dutta, R. et al. Demyelination causes synaptic alterations in hippocampi from multiple sclerosis patients. Annals of neurology 69, 445-454 (2011).
18. Geurts, J. J. et al. Extensive hippocampal demyelination in multiple sclerosis. Journal of neuropathology and experimental neurology 66, 819-827 (2007).
19. Patti, F. Treatment of cognitive impairment in patients with multiple sclerosis. Expert opinion on investigational drugs 21, 1679-1699 (2012).
20. Mi, S., Sandrock, A. & Miller, R. H. L. INGO-1 and its role in CNS repair. Te international journal of biochemistry & cell biology 40, 1971-1978 (2008).
21. Mi, S. et al. LINGO-1 negatively regulates myelination by oligodendrocytes. Nature neuroscience 8, 745-751 (2005).
22. Lee, X. et al. NGF regulates the expression of axonal LINGO-1 to inhibit oligodendrocyte diferentiation and myelination. Te Journal of neuroscience : the ofcial journal of the Society for Neuroscience 27, 220-225 (2007).
23. Mi, S. et al. LINGO-1 antagonist promotes spinal cord remyelination and axonal integrity in MOG-induced experimental autoimmune encephalomyelitis. Nature medicine 13, 1228-1233 (2007).
24. Maday, S., Twelvetrees, A. E., Moughamian, A. J. & Holzbaur, E. L. Axonal transport: cargo-specifc mechanisms of motility and regulation. Neuron 84, 292-309 (2014).
25. Flores, A. I. et al. Constitutively active Akt induces enhanced myelination in the CNS. Te Journal of neuroscience : the ofcial journal of the Society for Neuroscience 28, 7174-7183 (2008).
26. Goebbels, S. et al. Elevated phosphatidylinositol 3, 4, 5-trisphosphate in glia triggers cell-autonomous membrane wrapping and myelination. Te Journal of neuroscience : the ofcial journal of the Society for Neuroscience 30, 8953-8964 (2010).
27. Narayanan, S. P., Flores, A. I., Wang, F. & Macklin, W. B. Akt signals through the mammalian target of rapamycin pathway to regulate CNS myelination. Te Journal of neuroscience: the ofcial journal of the Society for Neuroscience 29, 6860-6870 (2009).
28. Snaidero, N. et al. Myelin membrane wrapping of CNS axons by PI(3, 4, 5)P3-dependent polarized growth at the inner tongue. Cell 156, 277-290 (2014).
29. Tyler, W. A. et al. Activation of the mammalian target of rapamycin (mTOR) is essential for oligodendrocyte diferentiation. Te Journal of neuroscience : the ofcial journal of the Society for Neuroscience 29, 6367-6378 (2009).
30. Politis, M. et al. Increased PK11195 PET binding in the cortex of patients with MS correlates with disability. Neurology 79, 523-530 (2012).
31. Achiron, A., Chapman, J., Tal, S., Bercovich, E. & Gil, H. Superior temporal gyrus thickness correlates with cognitive performance in multiple sclerosis. Brain structure & function 218, 943-950 (2013).
32. Huitinga, I. et al. Hypothalamic lesions in multiple sclerosis. Journal of neuropathology and experimental neurology 60, 1208-1218 (2001).
33. Kern, K. C. et al. Fornix damage limits verbal memory functional compensation in multiple sclerosis. NeuroImage 59, 2932-2940 (2012).
34. Levy Barazany, H. et al. Brain MRI of nasal MOG therapeutic efect in relapsing-progressive EAE. Experimental neurology 255, 63-70 (2014).
35. Vorhees, C. V. & Williams, M. T. Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nature protocols 1, 848-858 (2006).
36. Fields, R. D. Neuroscience. Myelin-more than insulation. Science (New York, N.Y.) 344, 264-266 (2014).
37. Haroutunian, V. et al. Myelination, oligodendrocytes, and serious mental illness. Glia 62, 1856-1877 (2014).
38. Nave, K. A. Myelination and the trophic support of long axons. Nature reviews. Neuroscience 11, 275-283 (2010).
39. Pepinsky, R. B. et al. Exposure levels of anti-LINGO-1 Li81 antibody in the central nervous system and dose-efcacy relationships in rat spinal cord remyelination models afer systemic administration. Te Journal of pharmacology and experimental therapeutics 339, 519-529 (2011).